title: [The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome].
abstract: The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010.
authors.affiliation: Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, España. jesus.millan@madrid.org
authors.forename: Jesús
authors.initials: J
authors.lastname: Millán Núñez-Cortés
authors.forename: Juan Pedro-Botet
authors.initials: JP
authors.lastname: Montoya
authors.forename: Xavier Pintó
authors.initials: XP
authors.lastname: Salas
authors.forename: Antonio
authors.initials: A
authors.lastname: Hernández Mijares
authors.forename: Vincent J
authors.initials: VJ
authors.lastname: Carey
authors.forename: Michel P
authors.initials: MP
authors.lastname: Hermans
authors.forename: Frank M
authors.initials: FM
authors.lastname: Sacks
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Fruchart
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000209:etiology; D000368:Aged; D000369:Aged, 80 and over; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology*; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D050171:Dyslipidemias / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015228:Hypertriglyceridemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007391:International Cooperation; D008055:Lipids / Q000097:blood*; D008297:Male; D008499:Medical Records / Q000706:statistics & numerical data; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D018579:Patient Selection; D012008:Recurrence; D012189:Retrospective Studies; D012306:Risk; D018570:Risk Assessment
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids